Search

Search Constraints

You searched for: Author/Creator Nakada, Mitsutoshi

Search Results

1. ACTR-04. BIOMARK: A PHASE II STUDY OF BEVACIZUMAB BEYOND PROGRESSION FOR NEWLY DIAGNOSED GLIOBLASTOMA: SAFETY, EFFICACY AND PROSPECTIVE BIOMARKER ANALYSIS. (11th November 2019)

2. ACTR-20. A SMALL MOLECULE AXL INHIBITOR, BGB324 – FIRST-IN-HUMAN GBM SURGICAL PK TRIAL FOR RECURRENT TUMORS. (5th November 2018)

5. Autophagy inhibition synergizes with calcium mobilization to achieve efficient therapy of malignant gliomas. Issue 8 (26th July 2018)

8. BOT-3 Prognostic Factors of CNS Germ Cell Tumors; Molecular and Histopathological Analyses on 154 Cases from the iGCT Consortium. (6th December 2021)

9. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity. (5th December 2017)

10. Cancer among children, adolescents and young adults in the Hokushin region, Japan, between 2010 and 2015. (16th November 2021)